Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00955851 · ClinicalTrials.gov registry record
A Study To Examine Serologic Response In Hospitalized Patients Receiving Polyvalent Pneumococcal Vaccine
A clinical trial, sponsored by George Washington University.
- Completed
- Registry status
- 25
- Enrollment target
NCT00955851 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 25 participants.
The verdict
NCT00955851 has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Investigators in the Division of Infectious Diseases and the Division of Hospital Medicine of The George Washington University Medical Center are carrying out a study to determine if hospitalized patients receiving the polyvalent pneumococcal vaccine during an acute illness develop an adequate antibody response. The study group will consist of individuals diagnosed with pneumonia and admitted to the Medicine ward under the Pneumonia Core Measure Protocol, which assigns appropriate patients for vaccination based on the current guidelines from the Advisory Committee on Immunization Practices (ACIP).
Interventions
- OTHER Pre and post vaccination titers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00955851
The ClinicalTrials.gov registry entry for NCT00955851 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pre and post vaccination titers is the first listed.
NCT00955851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00955851 about?
NCT00955851 is a clinical study titled "A Study To Examine Serologic Response In Hospitalized Patients Receiving Polyvalent Pneumococcal Vaccine". Investigators in the Division of Infectious Diseases and the Division of Hospital Medicine of The George Washington University Medical Center are carrying out a study to determine if hospitalized patients receiving the polyvalent pneumococcal vaccine during an acute illness develop an adequate antib...
What is the current status of trial NCT00955851?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2009-06. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00955851?
The interventions under investigation include: Pre and post vaccination titers (OTHER).
Who is sponsoring clinical trial NCT00955851?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.